期刊文献+

多排CT小肠成像鉴别小肠结核和克罗恩病的价值 被引量:6

Differential diagnosis of intestinal tuberculosis from Crohn's disease by multi-detector computed tomography enterography
下载PDF
导出
摘要 目的探讨多排CT小肠成像(MDCTE)特征性征象在鉴别诊断肠结核和克罗恩病中的价值。方法收集安徽医科大学第一附属医院2011年8月至2014年11月经内镜、病理确诊的克罗恩病(CD)22例、结核(ITB)25例患者临床资料。每位患者入院后均行MDCTE检查,记录并分析各种MDCTE征象,寻求鉴别诊断CD和ITB有价值的CT表现。结果 CD和ITB回盲瓣受累分别占54.5%和72.0%,累及降结肠的分别占31.8%和12.0%,累及横结肠分别占18.2%和4.0%;多节段受累患者中,CD组为63.6%,ITB为36.0%;肠系膜侧肠壁增厚在CD中占50.0%,ITB则表现为环形或肠系膜对侧增厚;60.0%的ITB患者和9.1%CD患者有淋巴结中心坏死;36.4%的CD患者出现"梳状征",ITB患者中仅有4.0%,两者差异均有统计学意义(P<0.05)。结论MDCTE征象中,病变节段数、病变累及部位、"梳状征"和淋巴结坏死情况在鉴别诊断CD和ITB中具有参考价值。 Objective To evaluatethe value of multi - detector CT enterography (MDCTE) in differential diagnosis intestinal tuber-culosis (ITB) and Crohn s disease ( CD) . Methods Twenty - two CD and twenty - five ITB patients were performed MDCTE scanning, then the value of MDCTE findings in differential diagnosis of CD and ITBwas evaluated. Results In patients with CD and ITB, involved the ileo-cecal valve, descending colon and transverse colon was54. 5% and 72. 0% ,31. 8% and 12. 0% , 18. 2% and 4. 0% , respectively. There were 63. 6% CD and 36. 0% ITB patients involved multistage intestine. Lymph nodenecrosis was detected in 60. 0% ITB and 9.1% CD pa-tients. Mesenteric side bowel wall thickening in 50. 0% of CD patients and ITB patients was circular thickening. There were 36.4% CD and 4.0% ITB patients with "comb" sign, and the difference was statistically significant(P 〈0.05). Conclusion Lesion segment number and location," comb" sign and lymph node necrosis are valuable MDCTE findings in differential diagnosis CD and ITB.
出处 《安徽医学》 2017年第7期834-836,共3页 Anhui Medical Journal
基金 安徽省高校自然基金重点项目(项目编号:KJ2011A179)
关键词 克罗恩病 肠结核 CT小肠成像 多排螺旋CT Crohns disease Intestinal tuberculosis Computed tomography enterography Multi - detector computed tomography
  • 相关文献

参考文献5

二级参考文献36

  • 1吴孟超,吴在德,黄家驷.外科学[M].7版.北京:人民卫生出版社,2008:1440-1441.
  • 2邓长辉,程光辉,杨学抗.肠结核38例手术治疗分析[J].中国误诊学杂志,2007,7(19):4631-4632. 被引量:19
  • 3郑琴芳,覃江,农兵.克罗恩病与肠结核临床及内镜表现的比较[J].内科,2007,2(4):519-520. 被引量:8
  • 4Silverberg MS,Satsangi J,Ahmad T,et al.Toward an integrated clinical,molecular and serological classification of inflammatory bowel disease:report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.Can J Gastroenterol,2005,19 Suppl A:5-36.
  • 5Satsangi J,Silverberg MS,Vermeire S,et al.The Montreal classification of inflammatory bowel disease:controversies,consensus,and implications.Gut,2006,55(6):749-53.
  • 6Ulysses dos Santos TORRES,Juliana Olsen RODRIGUES,Melissa Silva Garcia JUNQUEIRA,et al.The Montreal classification for Crohn's disease:clinical application to a Brazilian single-center cohort of 90 consecutive patients.Arq Gastroentero1,2010,47 (3):279-84.
  • 7Pigneur B,Seksik P,Viola S,et al.Natural history of Crohn's disease:comparison between childhood-and adult -onset disease.Inflamm Bowel Dis,2010,16(6):953-61.
  • 8Cosnes J,Gower-Rousseau C,Seksik P,Cortot A.Epidemiology and natural history of inflammatory bowel diseases.Gastroenterology,2011,140 (6):1785-94.
  • 9Langholz E.Current trends in inflammatory bowel disease:the natural history.Therap Adv Gastroenterol,2010,3 (2):77-86.
  • 10Steinhart AH,Forbes A,Mills EC,et al.Systematic review:the potential influence of mesalazine formulation on maintenance of remission in Crohn's disease.Aliment Pharmacol Ther,2007,25:1389-1399.

共引文献84

同被引文献40

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部